The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
C‐C chemokine receptor 2 (CCR2) deficiency improves bleomycin‐induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage‐derived matrix metalloproteinases
Open accessAbstract
Macrophage infiltration is implicated in various types of pulmonary fibrosis. One important pathogenetic process associated with pulmonary fibrosis is injury to basement membranes by matrix metalloproteinases (MMPs) that are produced mainly by macrophages. In this study, C‐C chemokine receptor 2‐deficient (CCR2−/−) mice were used to explore the relationship between macrophage infiltration and MMP activity in the pathogenesis of pulmonary fibrosis, using the bleomycin‐induced model of this disease process. CCR2 is the main (if not only) receptor for monocyte chemoattractant protein‐1/C‐C chemokine ligand 2 (MCP‐1/CCL2), which is a critical mediator of macrophage trafficking, and CCR2 −/− mice demonstrate defective macrophage migration. Pulmonary fibrosis was induced in CCR2−/− and wild‐type (CCR2+/+) mice by intratracheal instillation of bleomycin. No significant differences in the total protein concentration in bronchoalveolar lavage (BAL) fluid, or in the degree of histological lung inflammation, were observed in the two groups until day 7. Between days 3 and 21, however, BAL fluid from CCR2−/− mice contained fewer macrophages than BAL fluid from CCR2+/+ mice. Gelatin zymography of BAL fluid and in situ zymography revealed reduced gelatinolytic activity in CCR2−/− mice. Immunocytochemical staining showed weaker expression of MMP‐2 and MMP‐9 in macrophages in BAL fluid from CCR2−/− mice at day 3. Gelatin zymography of protein extracted from alveolar macrophages showed reduced gelatinolytic activity of MMP‐2 and MMP‐9 in CCR2−/− mice. At days 14 and 21, lung remodelling and the hydroxyproline content of lung tissues were significantly reduced in CCR2−/− mice. These results suggest that the CCL2/CCR2 functional pathway is involved in the pathogenesis of bleomycin‐induced pulmonary fibrosis and that CCR2 deficiency may improve the outcome of this disease by regulating macrophage infiltration and macrophage‐derived MMP‐2 and MMP‐9 production. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
GM-CSF Regulates Bleomycin-Induced Pulmonary Fibrosis Via a Prostaglandin-Dependent Mechanism
Moore, B. B., Coffey, M. J., Christensen, P., Sitterding, S., Ngan, R., Wilke, C. A., McDonald, R., Phare, S. M., Peters-Golden, M., Paine, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4032 · Cited by 158
Cited by
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Morse, C., Tabib, T., Sembrat, J., Buschur, K. L., Bittar, H. T., Valenzi, E., Jiang, Y., Kass, D. J., Gibson, K., Chen, W., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.02441-2018 · Cited by 822
Macrophages: Their role, activation and polarization in pulmonary diseases
Arora, S., Dev, K., Agarwal, B., Das, P., & Syed, M. A. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.11.001 · Cited by 639
Macrophages and Tissue Injury: Agents of Defense or Destruction?
Laskin, D. L., Sunil, V. R., Gardner, C. R., & Laskin, J. D. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105812 · Cited by 604
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.003 · Cited by 538
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Greenlee, K. J., Werb, Z., & Kheradmand, F. (2007) · Physiological Reviews · doi:10.1152/physrev.00022.2006 · Cited by 474
Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
Ruytinx, P., Proost, P., Van Damme, J., & Struyf, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01930 · Cited by 450
Macrophage polarization and allergic asthma
Saradna, A., Do, D. C., Kumar, S., Fu, Q.-L., & Gao, P. (2018) · Translational Research · doi:10.1016/j.trsl.2017.09.002 · Cited by 424
CCR2 promotes hepatic fibrosis in mice #
Seki, E., de Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N., Schwabe, R. F., & Brenner, D. A. (2009) · Hepatology · doi:10.1002/hep.22952 · Cited by 416
Immune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
The pathogenesis of pulmonary fibrosis: a moving target
Wuyts, W. A., Agostini, C., Antoniou, K. M., Bouros, D., Chambers, R. C., Cottin, V., Egan, J. J., Lambrecht, B. N., Lories, R., Parfrey, H., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00073012 · Cited by 356
Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis
McKleroy, W., Lee, T.-H., & Atabai, K. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00418.2012 · Cited by 261
Deletion of c-FLIP from CD11bhi Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis
McCubbrey, A. L., Barthel, L., Mohning, M. P., Redente, E. F., Mould, K. J., Thomas, S. M., Leach, S. M., Danhorn, T., Gibbings, S. L., Jakubzick, C. V., et al. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0154oc · Cited by 195
McCubbrey, A. L., Allison, K. C., Lee-Sherick, A. B., Jakubzick, C. V., & Janssen, W. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01618 · Cited by 114
Young, L. R., Gulleman, P. M., Short, C. W., Tanjore, H., Sherrill, T., Qi, A., McBride, A. P., Zaynagetdinov, R., Benjamin, J. T., Lawson, W. E., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.88947 · Cited by 105
Okabe, Y., Toda, E., Urushiyama, H., Terashima, Y., Kunugi, S., Kajimoto, Y., Terasaki, M., Matsushima, K., Saito, A., Yamauchi, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71770-z · Cited by 14
Self-citationM. S. Barron, A., Fabre, T., & De, S. (2024) · F1000Research · doi:10.12688/f1000research.143472.1 · Cited by 8
Metadata
- Authors
- Okuma, T., Terasaki, Y., Kaikita, K., Kobayashi, H., Kuziel, W. A., Kawasuji, M., & Takeya, M.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2004-11-10
- Volume
- 204
- Issue
- 5
- Pages
- 594-604
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2053642612
- Cited by
- 189
- References
- 2
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.